Foghorn Therapeutics Inc. (FHTX)

CIK 1822462 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Foghorn Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 6, 20268-K0001628280-26-053817
Aug 6, 202610-Q0001628280-26-053819
Jun 25, 202640001474056-26-000007
Jun 25, 202640001180763-26-000005
Jun 25, 202640001970274-26-000007
Jun 25, 202640001073385-26-000004
Jun 25, 202640001591109-26-000004
Jun 25, 202640001972849-26-000004
Jun 25, 202640001197032-26-000005
Jun 25, 202640001581956-26-000004
Jun 25, 202640001486373-26-000005
Jun 24, 20268-K0001628280-26-045154
May 15, 2026SCHEDULE 13G/A0000921895-26-001393
May 14, 2026SCHEDULE 13G/A0001193805-26-000608
May 7, 202610-Q0001628280-26-031671
May 7, 20268-K0001628280-26-031669
May 6, 2026SCHEDULE 13G/A0000315066-26-001195
Apr 30, 2026ARS0001193125-26-193958
Apr 30, 2026DEF 14A0001193125-26-193928
Apr 30, 2026DEFA14A0001193125-26-193948
Apr 21, 20268-K0001628280-26-026259
Apr 13, 202640001828724-26-000005
Mar 26, 2026S-80001628280-26-021405
Mar 11, 20268-K0001628280-26-016805
Mar 11, 202610-K0001628280-26-016814